These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22109111)

  • 1. Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.
    Yanoov-Sharav M; Leshinsky-Silver E; Cohen S; Vinkler C; Michelson M; Lerman-Sagie T; Ginzberg M; Sadeh M; Lev D
    J Genet Couns; 2012 Aug; 21(4):557-63. PubMed ID: 22109111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population.
    Wang ZQ; Wang N; van der Maarel S; Murong SX; Wu ZY
    Eur J Hum Genet; 2011 Jan; 19(1):64-9. PubMed ID: 20736973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
    Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
    Dai Y; Li P; Wang Z; Liang F; Yang F; Fang L; Huang Y; Huang S; Zhou J; Wang D; Cui L; Wang K
    J Med Genet; 2020 Feb; 57(2):109-120. PubMed ID: 31506324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
    Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM
    Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere.
    Thomas NS; Wiseman K; Spurlock G; MacDonald M; Ustek D; Upadhyaya M
    J Med Genet; 2007 Mar; 44(3):215-8. PubMed ID: 16987949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
    Lemmers RJ; Osborn M; Haaf T; Rogers M; Frants RR; Padberg GW; Cooper DN; van der Maarel SM; Upadhyaya M
    Neurology; 2003 Jul; 61(2):178-83. PubMed ID: 12874395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.
    Scionti I; Fabbri G; Fiorillo C; Ricci G; Greco F; D'Amico R; Termanini A; Vercelli L; Tomelleri G; Cao M; Santoro L; Percesepe A; Tupler R
    J Med Genet; 2012 Mar; 49(3):171-8. PubMed ID: 22217918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic analysis of Korean patients with facioscapulohumeral muscular dystrophy.
    Ki CS; Lee ST; Kim KS; Kim JW; Hong YH; Sung JJ; Park KS; Lee KW
    J Korean Med Sci; 2008 Dec; 23(6):959-63. PubMed ID: 19119436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of gene structure in facioscapulohumeral muscular dystrophy-related 4q35 subtelomere and genotype-phenotype correlation in Chinese Han population].
    Wang ZQ; Wu ZY; Wang N; Lin MT; Murong SX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):304-9. PubMed ID: 19563705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
    Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
    Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.
    Scionti I; Greco F; Ricci G; Govi M; Arashiro P; Vercelli L; Berardinelli A; Angelini C; Antonini G; Cao M; Di Muzio A; Moggio M; Morandi L; Ricci E; Rodolico C; Ruggiero L; Santoro L; Siciliano G; Tomelleri G; Trevisan CP; Galluzzi G; Wright W; Zatz M; Tupler R
    Am J Hum Genet; 2012 Apr; 90(4):628-35. PubMed ID: 22482803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].
    Jordan B; Müller-Reible C; Zierz S
    Nervenarzt; 2011 Jun; 82(6):712-22. PubMed ID: 21567298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?
    Barat-Houari M; Nguyen K; Bernard R; Fernandez C; Vovan C; Bareil C; Khau Van Kien P; Thorel D; Tuffery-Giraud S; Vasseur F; Attarian S; Pouget J; Girardet A; Lévy N; Claustres M
    Eur J Hum Genet; 2010 May; 18(5):533-8. PubMed ID: 19935833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent somatic mosaicism for D4Z4 contractions in a family with facioscapulohumeral muscular dystrophy.
    Buzhov BT; Lemmers RJ; Tournev I; van der Wielen MJ; Ishpekova B; Petkov R; Petrova J; Frants RR; Padberg GW; van der Maarel SM
    Neuromuscul Disord; 2005 Jul; 15(7):471-5. PubMed ID: 15935668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
    Zampatti S; Colantoni L; Strafella C; Galota RM; Caputo V; Campoli G; Pagliaroli G; Carboni S; Mela J; Peconi C; Gambardella S; Cascella R; Giardina E
    Neurogenetics; 2019 May; 20(2):57-64. PubMed ID: 30911870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants and recombination at 4q35: Hints for preimplantation genetic testing in facioscapulohumeral muscular dystrophy.
    Pini S; Napoli FM; Tagliafico E; La Marca A; Bertucci E; Salsi V; Tupler R
    Clin Genet; 2023 Feb; 103(2):242-246. PubMed ID: 36250762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of facioscapulohumeral muscular dystrophy.
    Tupler R; Gabellini D
    Cell Mol Life Sci; 2004 Mar; 61(5):557-566. PubMed ID: 15004695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.